Nu Skin/$NUS
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Nu Skin
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.
Ticker
$NUS
Sector
Primary listing
NYSE
Employees
2,800
Headquarters
Website
Nu Skin Metrics
BasicAdvanced
$408M
2.67
$3.18
1.01
$0.24
2.83%
Price and volume
Market cap
$408M
Beta
1.01
52-week high
$14.62
52-week low
$5.32
Average daily volume
576K
Dividend rate
$0.24
Financial strength
Current ratio
2.077
Quick ratio
1.067
Long term debt to equity
33.303
Total debt to equity
38.329
Dividend payout ratio (TTM)
7.39%
Interest coverage (TTM)
6.52%
Profitability
EBITDA (TTM)
143.342
Gross margin (TTM)
69.45%
Net profit margin (TTM)
10.79%
Operating margin (TTM)
6.12%
Effective tax rate (TTM)
18.35%
Revenue per employee (TTM)
$530,000
Management effectiveness
Return on assets (TTM)
3.95%
Return on equity (TTM)
22.00%
Valuation
Price to earnings (TTM)
2.667
Price to revenue (TTM)
0.281
Price to book
0.51
Price to tangible book (TTM)
0.6
Price to free cash flow (TTM)
9.085
Free cash flow yield (TTM)
11.01%
Free cash flow per share (TTM)
0.933
Dividend yield (TTM)
2.83%
Forward dividend yield
2.83%
Growth
Revenue change (TTM)
-14.26%
Earnings per share change (TTM)
-207.73%
3-year revenue growth (CAGR)
-12.61%
10-year revenue growth (CAGR)
-4.06%
3-year earnings per share growth (CAGR)
15.39%
10-year earnings per share growth (CAGR)
3.52%
3-year dividend per share growth (CAGR)
-46.19%
10-year dividend per share growth (CAGR)
-16.17%
What the Analysts think about Nu Skin
Analyst ratings (Buy, Hold, Sell) for Nu Skin stock.
Nu Skin Financial Performance
Revenues and expenses
Nu Skin Earnings Performance
Company profitability
Nu Skin News
AllArticlesVideos
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2025 Q4
Newsfile Corp·2 weeks ago
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
Business Wire·2 weeks ago
Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness
Business Wire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Nu Skin stock?
Nu Skin (NUS) has a market cap of $408M as of February 28, 2026.
What is the P/E ratio for Nu Skin stock?
The price to earnings (P/E) ratio for Nu Skin (NUS) stock is 2.67 as of February 28, 2026.
Does Nu Skin stock pay dividends?
Yes, the Nu Skin (NUS) stock pays dividends to shareholders. As of February 28, 2026, the dividend rate is $0.24 and the yield is 2.83%. Nu Skin has a payout ratio of 7.39% on a trailing twelve-month basis.
When is the next Nu Skin dividend payment date?
The next Nu Skin (NUS) dividend payment is scheduled for March 11, 2026.
What is the beta indicator for Nu Skin?
Nu Skin (NUS) has a beta rating of 1.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.